Clinical Trial Update: GDNF Gene Therapy for Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for glial cell-derived neurotrophic factor (GDNF) gene therapy for Parkinson's disease, sponsored by Brain Neurotherapy Bio, Inc.;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• GDNF Gene Therapy (glial cell-derived neurotrophic factor (GDNF) gene therapy)

Snippet

Sponsor: Brain Neurotherapy Bio, Inc. | Conditions: Parkinson's Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING